Endo Pharmaceuticals Inc. v. Amneal Pharmaceuticals, LLC
1:12-cv-08115
Overview
Parties
Defendant
Amneal Pharmaceuticals of New York, LLC Operating Company
Represented By
12 Attorneys ListedSterne, Kessler, Goldstein & Fox PLLC
1100 New York Avenue,NW, Washington, DC 20005
Robins, Kaplan LLP (NYC)
601 Lexington Avenue, Suite 3400, New York, NY 10022
Sterne, Kessler, Goldstein & Fox PLLC
1100 New York Avenue, NW, Washington, DC 20005
Sterne, Kessler, Goldstein & Fox P.L.L.C.
Sterne, Kessler, Goldstein & Fox P.L.L.C., 1100 New York Avenue, Nw
Salans FMC SNR Denton Europe LLP
620 Fifth Avenue, New York, NY 10020
Sterne Kessler Goldstein & Fox PLLC
1100 New York Ave, N.W., Washington, DC 20005
Sterne, Kessler, Goldstein & Fox P.L.L.C.
Sterne, Kessler, Goldstein & Fox P.L.L.C., Washington, DC 20005
Salans FMC SNR Denton Europe LLP
Rockefeller Center 620 Fifth Avenue, New York, NY 10020
Crowell & Moring LLP (NYC)
590 Madison Avenue, New York, NY 10022
Sterne, Kessler, Goldstein & Fox P.L.L.C.
Sterne, Kessler, Goldstein & Fox P.L.L.C., 1100 New York Avenue NW
Saiber LLC
Saiber LLC, 18 Columbia Turnpike
Saiber, L.L.C.
Saiber, L.L.C., 18 Columbia Turnpike, Suite 200
Amneal Pharmaceuticals, LLC Operating Company
Represented By
13 Attorneys ListedSterne, Kessler, Goldstein & Fox PLLC
1100 New York Avenue,NW, Washington, DC 20005
Robins, Kaplan LLP (NYC)
601 Lexington Avenue, Suite 3400, New York, NY 10022
Sterne, Kessler, Goldstein & Fox PLLC
1100 New York Avenue, NW, Washington, DC 20005
Sterne, Kessler, Goldstein & Fox P.L.L.C.
Sterne, Kessler, Goldstein & Fox P.L.L.C., 1100 New York Avenue, Nw
Salans FMC SNR Denton Europe LLP
620 Fifth Avenue, New York, NY 10020
Sterne Kessler Goldstein & Fox PLLC
1100 New York Ave, N.W., Washington, DC 20005
Sterne, Kessler, Goldstein & Fox P.L.L.C.
Sterne, Kessler, Goldstein & Fox P.L.L.C., Washington, DC 20005
Salans FMC SNR Denton Europe LLP
Rockefeller Center 620 Fifth Avenue, New York, NY 10020
Crowell & Moring LLP (NYC)
590 Madison Avenue, New York, NY 10022
Sterne, Kessler, Goldstein & Fox, P.L.L.C.
Sterne, Kessler, Goldstein & Fox, P.L.L.C., 1100 New York Avenue, N.W.
Sterne, Kessler, Goldstein & Fox P.L.L.C.
Sterne, Kessler, Goldstein & Fox P.L.L.C., 1100 New York Avenue NW
Saiber LLC
Saiber LLC, 18 Columbia Turnpike
Saiber, L.L.C.
Saiber, L.L.C., 18 Columbia Turnpike, Suite 200
Plaintiff
Grunenthal GMBH NPE (Individual / Inventor)
Represented By
11 Attorneys ListedFinnegan, Henderson, Farabow, Garrett & Dunner, LLP
901 New York Ave Nw, Washington, DC 20001
Finnegan, Henderson, Farabow, Garrett & Dunner LLP (DC)
901 New York Avenue, N.W., Washington, DC 20001
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
901 New York Ave., N.W., Washington, DC 20001
Wilk Auslander LLP
1515 Broadway, 43rd Floor, New York, NY 10036
Dechert LLP
Cira Centre 2929 Arch Street, US, PA 19104
Dechert, LLP (NYC)
1095 Avenue of the Americas, New York, NY 10036-6797
Finnegan, Henderson, Farabow, Garrett & Dunner LLP (DC)
901 New York Avenue, N.W., Washington, DC 20001
Finnegan, Henderson, Farabow, Garrett & Dunner LLP (DC)
901 New York Avenue, N.W., Washington, DC 20001
Finnegan, Henderson, Farabow, Garrett & Dunner LLP (DC)
901 New York Avenue, N.W., Washington, DC 20001
Finnegan, Henderson, Farabow, Garrett & Dunner LLP (DC)
901 New York Avenue, N.W., Washington, DC 20001
Endo Pharmaceuticals Inc. Operating Company
Represented By
16 Attorneys ListedDechert LLP
902 Carnegie Center - Suite 500, Princeton, NJ 08540
Wilk Auslander LLP
1515 Broadway, 43rd Floor, New York, NY 10036
Dechert LLP
Cira Centre, 2929 Arch Street, Philadelphia, PA 19104
Dechert, LLP
502 Carnegie Center, Ste 104
Dechert LLP
Cira Centre 2929 Arch Street, US, PA 19104
Dechert, LLP (NYC)
1095 Avenue of the Americas, New York, NY 10036-6797
Dechert LLP
2440 W. El Camino Real, Suite 700, Mountain View, CA 94040
Finnegan, Henderson, Farabow, Garrett & Dunner LLP (DC)
901 New York Avenue, N.W., Washington, DC 20001
Finnegan, Henderson, Farabow, Garrett & Dunner LLP (DC)
901 New York Avenue, N.W., Washington, DC 20001
Dechert, LLP (NYC)
1095 Avenue of the Americas, New York, NY 10036-6797
Dechert LLP
2440 W El Camino Real, Sutie 700, Mountain View, CA 94040
Dechert LLP (PA)
Cira Centre, 2929 Arch Street
Dechert LLP (TX)
300 WEst 6th Street, Suite 2010, Austin, TX 78701
Finnegan, Henderson, Farabow, Garrett & Dunner LLP (DC)
901 New York Avenue, N.W., Washington, DC 20001
Finnegan, Henderson, Farabow, Garrett & Dunner LLP (DC)
901 New York Avenue, N.W., Washington, DC 20001
DECHERT LLP
2440 W. El Camino Real, Suite 700, Mountain View, CA 94040
Court & Judges
Court
District Court, S.D. New York (nysd)
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 2 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | Asserted Patent | View Official Patent → |
| 🇬🇧 United Kingdom | United Kingdom Counterpart | View Official Patent → |
Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals, Inc.
Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals, Inc.
Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals, Inc.
Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals Inc.
Endo Pharmaceuticals Inc. v. Roxane Laboratories, Inc.
Endo Pharmaceuticals Inc. v. Actavis Inc.
Endo Pharmaceuticals Inc. v. Impax Laboratories, Inc.
Endo Pharmaceuticals Inc., and Grunenthal GbmH v. Teva Pharmaceuticals USA, Inc., and Barr Laboratories, Inc.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7851482
Method for making analgesics
|
Filed: 2007-10-03
Issued: 2010-12-14
|
Active (2.6 yrs remaining)
+646d PTA
Expires: 2029-07-10
|
|
|
US8309122
Oxymorphone controlled release formulations
|
Filed: 2007-02-28
Issued: 2012-11-13
|
Expired (Term Ended)
Expires: 2026-03-08
|
|
|
US8329216
Oxymorphone controlled release formulations
|
Filed: 2006-06-29
Issued: 2012-12-11
|
Expired (Term Ended)
Expires: 2025-10-07
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
High PTA (+646 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
30
Dispositive
3
Granted
0
Denied
0
Pending / Review
19
Motions by Category
Key Dispositive Motions & Rulings